Skip Navigation
Menu

姜寅隮(カン・インジェ) 弁護士

T.+82-2-3703-4760 F.+82-2-737-9091/9092
カン・インジェ 弁護士
カン・インジェ 弁護士

姜寅隮(カン・インジェ)弁護士

T.+82-2-3703-4760 F.+82-2-737-9091/9092 E.inje.kang@kimchang.com

関連分野

紹介

Inje Kang is an attorney at Kim & Chang who specializes in the areas of corporate compliance consulting, internal investigation and anti-corruption. He also has various work experiences in digital forensics and legal tech, and AI/IT-based compliance monitoring systems, such as the establishment of a continuous IT monitoring system.

Mr. Kang possesses extensive experience in establishing and strengthening compliance systems for corporations and providing relevant improvement measures. He has successfully established and strengthened compliance systems for companies in the chemical, food, tourism, technology, distribution, machinery, automobile, steel, defense, electronics, pharmaceutical and heavy industries.

Employing his in-depth knowledge of the health industry, which incorporates the pharmaceutical, medical device, food and cosmetics industries, Mr. Kang has advised on matters relating to industry-specific regulations, fair trade, advertising, labor and employment, mergers and acquisitions and distribution. He has also represented multiple global companies before the Korean regulators, such as the Prosecutors’ Office and the Korea Fair Trade Commission, on a diverse range of cases.

In particular, Mr. Kang shows excellent expertise in projects where effective and legitimate advice can be provided only after obtaining a full understanding of the business characteristics, size, corporate culture and current situation of the business.

Based on his outstanding presentation skills, Mr. Kang gives lectures on compliance, ESG, anti-corruption and industry specific regulations to a number of client companies, universities, Thomson Reuters, the Korea Human Resource Development Institute, the Korea Research-Based Pharma Industry Association, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and other institutions and organizations, and actively participates in external activities.

プロフィール

経歴

Kim & Chang (2015-Present)
 

学歴

    University of San Diego School of Law (Visiting Scholar, 2023)

    Judicial Research and Training Institute of the Supreme Court of Korea (2015)

    Seoul National University (B.A., Major in Korean History and Minor in Law, 2010)

資格

    Admitted to bar, Korea, 2015

    ISO 37001 ABMS (anti-bribery management system) Certification Institute, 2017

言語

韓国語, 英語

関連分野

Close

業務分野

레이어 닫기

共有する

Close
  

姜寅隮(カン・インジェ)
弁護士


T. +82-2-3703-4760      
F. +82-2-737-9091/9092
     


  




Inje Kang is an attorney at Kim & Chang who specializes in the areas of corporate compliance consulting, internal investigation and anti-corruption. He also has various work experiences in digital forensics and legal tech, and AI/IT-based compliance monitoring systems, such as the establishment of a continuous IT monitoring system.

Mr. Kang possesses extensive experience in establishing and strengthening compliance systems for corporations and providing relevant improvement measures. He has successfully established and strengthened compliance systems for companies in the chemical, food, tourism, technology, distribution, machinery, automobile, steel, defense, electronics, pharmaceutical and heavy industries.

Employing his in-depth knowledge of the health industry, which incorporates the pharmaceutical, medical device, food and cosmetics industries, Mr. Kang has advised on matters relating to industry-specific regulations, fair trade, advertising, labor and employment, mergers and acquisitions and distribution. He has also represented multiple global companies before the Korean regulators, such as the Prosecutors’ Office and the Korea Fair Trade Commission, on a diverse range of cases.

In particular, Mr. Kang shows excellent expertise in projects where effective and legitimate advice can be provided only after obtaining a full understanding of the business characteristics, size, corporate culture and current situation of the business.

Based on his outstanding presentation skills, Mr. Kang gives lectures on compliance, ESG, anti-corruption and industry specific regulations to a number of client companies, universities, Thomson Reuters, the Korea Human Resource Development Institute, the Korea Research-Based Pharma Industry Association, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association and other institutions and organizations, and actively participates in external activities.






    Kim & Chang (2015-Present)
     






Compliance Consulting
 
  •   Advised on the effectiveness check and improvement strategies for compliance programs of major domestic and international companies.
  •   Provided consulting services on the compliance status of overseas subsidiaries of major domestic and international companies.
  •   Advised on establishing Compliance SOPs for global pharmaceutical, distribution, chemical and consumer goods companies.
  •   Advised on building an AI/IT-based continuous compliance monitoring system for domestic companies.
  •   Advised major domestic and international corporations on building and strengthening comprehensive compliance systems.

          - Advised on risk diagnosis (Risk Mapping) and improvement.
         - Advised on strengthening employee training systems.
         - Advised on improving internal policies and enhancing work procedures (including Process Innovation).
         - Advised on reinforcing internal audit systems.
         - Advised on Compliance Self-Diagnosis Toolkits (covering multiple areas including anti-corruption, fair trade, trade secrets and labor relations).
         - Advised on strengthening internal reporting systems.
         - Evaluated the effectiveness of compliance control standards.
         - Advised on responding to regulatory changes related to directors’ compliance oversight obligations.

Anti-Corruption and Corporate Compliance

  •   Advised on responding to investigations by regulatory authorities overseas for major domestic and international companies.
  •   Advised on establishing FCPA risk management systems (including third-party agent management processes) for major domestic and international companies.
  •   Advised on conducting internal investigations for major domestic and international companies.
  •   Advised on responding to investigations by the Anti-Corruption and Civil Rights Commission regarding violations of the Improper Solicitation and Graft Act.
  •   Advised on responding to investigations by prosecutors and the police regarding corruption allegations under the Criminal Code and the Improper Solicitation and Graft Act.


Healthcare

  •   Advised on unique regulatory issues related to the Pharmaceutical Affairs Act and Medical Device Act for major domestic pharmaceutical and medical device companies.
  •   Advised on executing regulatory improvement, relaxation and legislative amendment projects for major domestic pharmaceutical and medical device companies.
  •   Advised on responding to police and prosecution investigations related to the double penalty system for rebates.
  •   Advised on responding to investigations by the Fair Trade Commission regarding unfair trading practices in the pharmaceutical and medical device sectors.
  •   Advised on responding to investigations regarding unfair joint actions and obstruction of business operations by the Fair Trade Commission.
  •   Advised on responding to administrative actions related to violations of the Pharmaceutical Affairs Act and Medical Device Act.
  •   Advised on developing IT solutions for expenditure reporting in accordance with the Pharmaceutical Affairs Act and Medical Device Act, integrated with existing corporate IT systems.
  •   Advised on establishing product safety management systems for domestic conglomerates.





学歴

    University of San Diego School of Law (Visiting Scholar, 2023)

    Judicial Research and Training Institute of the Supreme Court of Korea (2015)

    Seoul National University (B.A., Major in Korean History and Minor in Law, 2010)


資格

    Admitted to bar, Korea, 2015

    ISO 37001 ABMS (anti-bribery management system) Certification Institute, 2017


言語
  •    韓国語, 英語





腐敗防止・コンプライアンス経営 ,  製薬·医療機器·食品·化粧品 ,  ESG ,  企業刑事・ホワイトカラー犯罪 ,  公正取引 ,  訴訟